|
|
|
Thu 9 Apr 2026
Close: 20095c 
Day's move: -119c (-0.59%)
Volume: 1 533 045
Trades: 3 865
|
|
|
|
Remgro Ltd. - Acceptance of awards by executive di
A director has dealt in shares of the company.
|
|
Click here for original article
|
| |
Remgro - restructuring of Mediclinic interests
Remgro announced a restructuring of its interests in Mediclinic International Ltd. The transaction involves two components: Remgro will acquire 100% of the South African MCSA Group, and Investment Holding Ltd. SARL will acquire 100% of the Swiss Hirslanden Group. Both transactions are valued at USD950 million each, based on valuations as of 30 June 2025. The deal aims to align ownership with local markets, enhance operational agility, and unlock value. The transaction is classified as a category 2 for Remgro and will be subject to various conditions precedent, including regulatory approvals. Shareholders are no longer cautioned from trading Remgro securities.
|
|
Click here for original article
|
| |
Remgro - trading statement
Remgro's results for the six months ended 31 December 2025 (current period) are due to be released on the Stock Exchange News Service (SENS) on or about 25 March 2026.
Remgro's headline earnings per share (HEPS) for the current period is expected to be between 914 cents and 948 cents compared to the HEPS of 672 cents for the reported comparative six months ended 31 December 2024, an expected increase of between 36% and 41%.
|
|
Click here for original article
|
| |
| |
| Click here for full news archive for this company |
|
| Closing price data source: JSE Ltd. All other statistics calculated by ProfileData. |
| |
|
|
